Crinetics Pharmaceuticals, Inc. - 8-K Filing

Crinetics Pharmaceuticals entered into a merger agreement with Vertex Pharmaceuticals and executed non-compete agreements with key executives. (Items: 1.01 Entry into a Material Definitive Agreement In connection with the entry into the Agreement and Plan of Merger, dated July 6, 2026 (the “Merge, 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)

SEC EDGAR ·

Tickers: $CRNX

Read the full article at SEC EDGAR

More Regulatory news